Supplementary Figure 7: Loss of RASSF1A does not correlate with increased mutation frequency.

Correlation of RASSF1 promoter methylation (assessed with illumina HM450) with genomic mutation count in lung adenocarcinoma datasets from the cancer genome atlas database (TCGA, Provisional). A total of 115 patients with Lung Adenocarcinoma were analysed using the Fisher’s exact test. Absolute numbers and P values are presented in the table.